VHCP Management III »

Nextcure shares owned by VHCP Management III

Quarter-by-quarter ownership of Nextcure (NXTC) shares owned by VHCP Management III from 13F filings

Historical chart of VHCP Management III investment in Nextcure

Tip: Access up to 7 years of quarterly data

All positions including Nextcure held by VHCP Management III consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nextcure by VHCP Management III

Quarter filed Position value Share count Share price at filing
2019-12-31 $6.7M 120k 56.33

More positions owned by VHCP Management III

Axsome Therapeutics (AXSM)
Constellation Pharmceticls I
Milestone Pharmaceuticals (MIST)
Relmada Therapeutics (RLMD)
89bio (ETNB)
10x Genomics Inc Cl A (TXG)
Forty Seven
Intra Cellular Therapies (ITCI)
Iveric Bio
Kalvista Pharmaceuticals (KALV)
Adverum Biotechnologies
Marinus Pharmaceuticals
Mersana Therapeutics (MRSN)
Myovant Sciences
Nextcure (NXTC)

View all positions for VHCP Management III

Top funds holding Nextcure

Sofinnova Ventures
Logos Global Management
Affinity Asset Advisors
OrbiMed Advisors
Vanguard Group
BlackRock
Tang Capital Management
Cable Car Capital
Long Focus Capital Management
Acadian Asset Management
Renaissance Technologies
Acuitas Investments
Federated Investors
BML Capital Management
Cardiff Park Advisors

View all funds holding Nextcure